This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Gemcitabine-resistant metastatic pancreatic cancer could be treated by raltitrexed-eloxatin salvage chemotherapy.
We care about your feedback. Let us know how we can improve your CancerCompass experience.